I'm currently working on a variant calling pipeline for some Whole Exome Sequencing (WES) data, and I've encountered a bit of a dilemma. The exome capture kit that was originally used for my data is the Agilent SureSelect DNA - SureSelect Human All Exon V6 r2, which is based on the hg19 (GRCh37) reference genome. However, I want to use SureSelect v7, which is designed for the hg38 reference genome.
My question is: Can I safely use the SureSelect v7 bed or would it be too risky given that the original data was captured with a kit based on hg19? What are the potential pitfalls of this approach, and would it significantly affect the accuracy or reliability of the variant calls? Any insights or suggestions would be greatly appreciated!
Hey, thank you for your comprehensive response, didn't know all that.